Understanding the Real Survival Advantages Provided By Provenge (Sipuleucel-T) for Men with Metastatic Prostate Cancer
Cancer ABCs From Surviving To Thriving - How to Thrive with Cancer
English - September 16, 2019 17:00 - 42 minutes - 29.1 MB - ★★★★★ - 6 ratingsMedicine Health & Fitness Science cancer prostate cancer rare cancers more than one cancer cancer thriver cancer survivor cancer survivorship living with cancer multiple cancers cancer support Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Prostate Cancer Surgical Incontinence Solutions
Next Episode: Prostate Cancer Treatment in the COVID-19 Era
Written Transcript at:
https://www.cancerabcs.org/transcript-provengesurvivaladvantage
Dr. Tim Richardson talks with Joel Nowak talk about the real survival advantages that the immunotherapy known as Provenge (sipuleucel-T) offers to men, especially men who get the therapy while their PSA is low (Schellhammer data) and men with an African-American background.
Along the way, they also talk about what is immunotherapy, how it works, how Provenge is actually administered, its side effects and who should get the treatment and where in their treatment schedule would it be best to get the treatment.